| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Gregory J Gores | Q91520926 |
| P2093 | author name string | Jayant A Talwalkar | |
| P433 | issue | 5 Suppl 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | S126-32 | |
| P577 | publication date | 2004-11-01 | |
| P1433 | published in | Gastroenterology | Q4039279 |
| P1476 | title | Diagnosis and staging of hepatocellular carcinoma. | |
| P478 | volume | 127 |
| Q38652256 | A new key player in VEGF-dependent angiogenesis in human hepatocellular carcinoma: dimethylarginine dimethylaminohydrolase 1. |
| Q45403763 | Accuracy of clinical criteria for the diagnosis of hepatocellular carcinoma without biopsy in a Hepatitis B virus-endemic area |
| Q37345951 | Advances in prevention and diagnosis of hepatocellular carcinoma |
| Q54563417 | Clinicopathological differences between hepatitis B viral genotype B- and C-related resectable hepatocellular carcinoma. |
| Q42999544 | Comparison of cancer care for hepatocellular carcinoma at two tertiary-care referral centers from high and low endemic regions for viral hepatitis |
| Q30490554 | Diagnosis of hepatocellular carcinoma. |
| Q46035308 | Evaluation of alpha-fetoprotein in detecting hepatocellular carcinoma recurrence after radiofrequency ablation. |
| Q45374862 | Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis. |
| Q37290714 | Evolving therapies in the treatment of hepatocellular carcinoma |
| Q36497118 | Fibroblast growth factor-4 and hepatocyte growth factor induce differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocytes |
| Q91740498 | HAMP Downregulation Contributes to Aggressive Hepatocellular Carcinoma via Mechanism Mediated by Cyclin4-Dependent Kinase-1/STAT3 Pathway |
| Q34056283 | HURP expression-assisted risk scores identify prognosis distinguishable subgroups in early stage liver cancer |
| Q28081456 | Hepatocellular carcinoma among cirrhotics--utility of screening and surveillance programs--review article |
| Q37403255 | Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992-2008. |
| Q79763478 | Hepatocellular carcinoma in an Australian tertiary referral hospital 1975-2002: change in epidemiology and clinical presentation |
| Q48227514 | Hepatocellular carcinoma presenting as nervous system involvement |
| Q35986436 | Hepatocellular carcinoma: focus on different aspects of management |
| Q36377949 | Hepatocellular carcinoma: therapy and prevention |
| Q36175681 | High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases |
| Q42280446 | IL17A gene polymorphisms, serum IL-17A and IgE levels, and hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection |
| Q79368645 | Is post-Lipiodol CT better than i.v. contrast CT scan for early detection of HCC? A single liver transplant center experience |
| Q36962089 | Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome |
| Q36571466 | MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma |
| Q34785204 | Occult and Overt HBV Co-Infections Independently Predict Postoperative Prognosis in HCV-Associated Hepatocellular Carcinoma |
| Q46196061 | Osteopontin promoter polymorphisms at locus -443 significantly affect the metastasis and prognosis of human hepatocellular carcinoma |
| Q43005656 | Overexpression of aspartyl-(asparaginyl)-beta-hydroxylase in hepatocellular carcinoma is associated with worse surgical outcome |
| Q36567898 | PCDH8 is Frequently Inactivated by Promoter Hypermethylation in Liver Cancer: Diagnostic and Clinical Significance |
| Q34606080 | Role of serum interleukin-18 as a prognostic factor in patients with hepatocellular carcinoma |
| Q36225257 | Single-nucleotide polymorphism at CYP27B1-1260, but not VDR Taq I, is possibly associated with persistent hepatitis B virus infection |
| Q41917123 | Sustained treatment response of metastatic hepatocellular carcinoma with bevacizumab and sorafenib |
| Q37504684 | Targeted therapy for hepatocellular carcinoma |
| Q53600472 | The diagnostic value of on-site cytopathological evaluation and cell block preparation in fine-needle aspiration cytology of liver masses. |
| Q33272872 | The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis. |
| Q54988323 | Utility of endoscopic ultrasound and endoscopy in diagnosis and management of hepatocellular carcinoma and its complications: What does endoscopic ultrasonography offer above and beyond conventional cross-sectional imaging? |
| Q41060206 | Utility of screening for hepatocellular carcinoma among cirrhotics |
| Q36715087 | Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma |
| Q53466302 | [Imaging nodules within cirrhotic liver: how do I do it?]. |
| Q82728683 | [Primary liver cancer] |
| Q53526177 | [Should we screen for hepatocellular carcinoma?]. |
| Q79317779 | [What changes were made in the National Thesaurus of Gastrointestinal Cancer in 2005?] |
| Q54291605 | [When only the pathologist may help. Limitation and possibilities of biopsies in Internal Medicine]. |
Search more.